Share on StockTwits

Cardiovascular Systems (NASDAQ:CSII) VP Kevin J. Kenny unloaded 6,779 shares of the company’s stock on the open market in a transaction dated Thursday, February 20th. The shares were sold at an average price of $36.02, for a total value of $244,179.58. Following the sale, the vice president now directly owns 82,325 shares in the company, valued at approximately $2,965,347. The sale was disclosed in a document filed with the SEC, which is available at this link.

Cardiovascular Systems (NASDAQ:CSII) traded up 0.25% during mid-day trading on Friday, hitting $36.59. 285,707 shares of the company’s stock traded hands. Cardiovascular Systems has a 52-week low of $15.28 and a 52-week high of $37.13. The stock has a 50-day moving average of $32.16 and a 200-day moving average of $27.40. The company’s market cap is $1.098 billion.

Cardiovascular Systems (NASDAQ:CSII) last issued its quarterly earnings data on Wednesday, January 29th. The company reported ($0.32) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.34) by $0.02. The company had revenue of $32.30 million for the quarter, compared to the consensus estimate of $30.62 million. The company’s revenue for the quarter was up 27.7% on a year-over-year basis. Analysts expect that Cardiovascular Systems will post $-1.25 EPS for the current fiscal year.

CSII has been the subject of a number of recent research reports. Analysts at Zacks downgraded shares of Cardiovascular Systems from an “outperform” rating to a “neutral” rating in a research note on Wednesday, February 5th. They now have a $36.80 price target on the stock. Separately, analysts at Benchmark Co. upgraded shares of Cardiovascular Systems from a “hold” rating to a “buy” rating in a research note on Thursday, January 30th. They now have a $38.00 price target on the stock, up previously from $35.00. Finally, analysts at Wunderlich raised their price target on shares of Cardiovascular Systems from $34.00 to $41.00 in a research note on Friday, January 10th. They now have a “buy” rating on the stock. One equities research analyst has rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the stock. The stock has an average rating of “Buy” and a consensus price target of $37.80.

Cardiovascular Systems, Inc (NASDAQ:CSII) is a medical device company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.